30th Apr 2014 10:18
LONDON (Alliance News) - Allergy Therapeutics PLC said that following the recent inspection of its facilities in Worthing by the Medicines and Healthcare Products Regulatory Agency, the firm Wednesday received its Certificate of GMP Compliance for the site.
The specialty pharmaceutical firm said it has invested more than GBP10 million to upgrade of its injectibles' facility over the past seven years, leading to manufacturing capacity of 210,000 allergy vaccines and diagnostic tests at the site.
"The significant enhancements we have made, combined with the highest quality values, means that our facilities are now prepared for producing clinical trial material for US trials," said Ian Postlethwaite, Finance Director at Allergy Therapeutics.
Shares in the company were trading 2.04% lower at 18.00 pence per share Wednesday morning.
By Alice Attwood; [email protected]; @AliceAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Allergy Thera.